Institute of Pathology

Mutations in the BAF-complex subunit DPF2 are associated with Coffin-Siris syndrome (2019) Vasileiou G, Vergarajauregui S, Endele S, Popp B, Büttner C, Ekici AB, Gerard M, et al. Conference contribution Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC) (2019) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Goeppinger S, Schwamborn K, Hieke-Schulz S, et al. Conference contribution Strong expression of EZH2 and H3K27me3 is associated with poor survival time in small cell lung cancer (2019) Fernandes AP, Alves RDS, Watte G, Kunze P, Roehe AV, Schneider-Stock R Conference contribution Tumor budding: A predictor for metastasis in the CAM xenograft model (2019) Muenzner JK, Ranjan RA, Eckstein M, Erber R, Kunze P, Geppert CI, Rübner M, et al. Conference contribution Protein levels of Piwi-like 1 and-2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert CI, Agaimy A, et al. Conference contribution Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency (2019) -Klein MW, Grujovic A, Obradovic M, Hoffmann M, Lu X, Kirsch S, Treitschke S, et al. Conference contribution New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story? (2019) Eckstein M, Gupta S Journal article, Editorial MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation (2019) Baran C, Agaimy A, Wehrhan F, Weber M, Hille V, Brunner K, Wickenhauser C, et al. Journal article Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go (2019) Gevaert T, Cimadamore A, Eckstein M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R Journal article, Review article Relevance of receptor for advanced glycation end products (RAGE) in murine antibody-mediated autoimmune diseases (2019) Eichhorst A, Daniel C, Rzepka R, Sehnert B, Nimmerjahn F, Voll RE, Chevalier N Journal article